A negative CTA can sound like a clean ending. In a new, painful, pupil-involving third-nerve palsy, it is better treated as a result to interpret: did the study answer the right question, and was it reviewed with enough confidence to change the plan?
Consider a 48-year-old man with diabetes who develops acute left retro-orbital pain, diplopia, ptosis, impaired adduction and vertical movements, and a larger, sluggish left pupil. Noncontrast head CT shows no hemorrhage or mass. The CTA report says no aneurysm—but the case gives no information about image quality, coverage, or who interpreted it. Those gaps matter. Do not assume the scan was inadequate; do not assume it was definitive, either. Because a compressive aneurysm remains a time-sensitive concern in this presentation, do not let a negative report defer urgent specialist review.
The immediate task is to assess a potentially dangerous cause without turning catheter angiography into an automatic reflex. Diabetes may make an ischemic palsy plausible; it does not settle the cause of this presentation or make vascular review optional.
First separate what each study can answer
A normal noncontrast CT and a negative CTA are not interchangeable. The first looks for acute blood and other gross abnormalities; vascular imaging is needed to assess the arteries. A vascular study can also be technically limited or interpreted without the key clinical context. Meanwhile, MRI may help investigate other causes of a third-nerve palsy, but it answers a different question from an unresolved vascular study.
| Study | What it helps assess | What it does not settle by itself |
|---|---|---|
| Noncontrast head CT | Acute hemorrhage and some gross structural abnormalities | Whether an aneurysm is present |
| CTA or MRA | Intracranial vascular anatomy, using a noninvasive approach | Whether the study was diagnostic and expertly interpreted, or what nonvascular process caused the palsy |
| MRI, selected with attention to the clinical localization | The nerve and surrounding tissues, and alternative structural causes | Whether an uncertain vascular result can be treated as conclusive |
| Catheter angiography (DSA) | Detailed catheter-based vascular assessment, sometimes linked to intervention | A routine next step for every patient with a negative noninvasive study |
The studies are complementary, not competing tests in a single ladder. The next choice depends on the unresolved question and on the quality and interpretation of the imaging already obtained.
Make the negative report answer the actual question
Before deciding that the aneurysm concern is settled, connect the clinical finding to the radiology review. Send the specific indication: acute, side-specific, partial third-nerve-pattern weakness with pupillary involvement, and concern for an aneurysm compressing the nerve. A vague request such as “headache” may not focus the interpretation on the relevant finding.
Then establish whether the images—not just the report—have been reviewed by someone experienced in neurovascular imaging. Ask whether the study is technically diagnostic and whether the relevant intracranial arterial anatomy can be assessed. Source images and available reconstructions may help resolve a discrepancy between the examination and the report. If the original study is limited or the interpretation remains uncertain, document that uncertainty rather than calling the result a confident negative.
This is not a theoretical distinction. In a selected retrospective series of patients with painful third-nerve palsy caused by aneurysm, some aneurysms missed in outside reports were identified on expert review of the images. Because the series included patients already known to have aneurysms, it does not estimate the false-negative rate of CTA or MRA. Its practical lesson is narrower: a report is only useful when the study and its interpretation address the clinical question.
Choose the next step from the remaining uncertainty
If CTA is technically adequate and an experienced reviewer agrees that no aneurysm is seen, DSA is not automatically required. That result is reassuring, but the clinician still has to decide whether the examination, symptom evolution, and study quality leave meaningful concern. This decision is best made with appropriate neurovascular and neuro-ophthalmic input, taking the risks and potential benefit of an invasive test into account.
If vascular suspicion remains high despite a reassuring report, or if the study is equivocal, technically limited, or not confidently interpreted, escalate the review promptly. Depending on the unresolved issue and local expertise, the team may consider expert rereading, additional noninvasive vascular imaging, or DSA. When concern persists after normal CTA or MRA, specialty guidance supports considering catheter angiography after brain MRI with and without contrast and specific attention to the third nerve; it does not make DSA a mandatory sequel to every negative scan.
If the vascular question is adequately addressed but the palsy remains unexplained, MRI can help evaluate the third nerve and surrounding structures for nonaneurysmal causes. The choice of coverage and contrast should match the suspected localization and the clinical question. A normal CTA does not itself explain the palsy, and a negative MRI does not retroactively improve an inadequate vascular study.
The history and examination should be specific enough to judge whether the case is changing. The scenario establishes an acute onset, but does not tell us his prior pupil sizes, ocular alignment, or whether he has had diplopia before; ask rather than assume. Clarify the evolution and impact of the symptoms, and repeat the neurologic and ocular-motor examination if they worsen or new findings appear. Progression or new neurologic signs should prompt renewed localization and urgent reassessment, not reassurance based solely on the first report.
Common traps
- Anchoring on diabetes: a vascular risk factor is not proof of a microvascular palsy.
- Confusing CT with CTA: a normal noncontrast CT does not answer the aneurysm question.
- Treating a report as the image: when clinical concern persists, verify the study’s quality, indication, and expert interpretation.
- Ordering DSA reflexively: it is a selective escalation, not an automatic requirement after every negative CTA.
- Letting vascular imaging close the entire case: once the aneurysm concern is addressed, consider whether MRI or other evaluation is needed to explain the palsy.
Practical takeaways
- In acute painful, pupil-involving third-nerve palsy, a negative CTA should be interpreted in context—not used as a stand-alone reassurance.
- Confirm that the study was diagnostic and reviewed with the correct, side-specific clinical question.
- Use MRI to investigate alternative structural causes when clinically indicated; it complements rather than replaces vascular assessment.
- Discuss DSA when suspicion remains high or noninvasive imaging is inconclusive, balancing the potential benefit against procedural risk.
- Diabetes may inform the differential, but it does not replace urgent evaluation or a follow-up plan.
